$402.59
+6.80 (+1.72%)
At Close: Jul 31, 2026
HCA Healthcare Reports Second Quarter 2026 Results
07:30am, Friday, 24'th Jul 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating re
HCA Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm
04:10pm, Thursday, 23'rd Jul 2026
RADNOR, Pa., July 23, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the feder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
10:00am, Thursday, 23'rd Jul 2026
NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to co
HCA Healthcare, Inc. Investigated by the Portnoy Law Firm
01:15pm, Wednesday, 22'nd Jul 2026
LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HCA Healthcare, Inc., (“HCA" or the "Company") (NYSE: HCA) investors that the firm has initiated an investigation into pos
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In HCA To Contact Him Directly To Discuss Their Options If you purchased or acquired stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
01:37pm, Tuesday, 21'st Jul 2026
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are ad
RADNOR, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the f
HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
08:00pm, Monday, 20'th Jul 2026
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA).
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the fed
Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?
01:16pm, Monday, 20'th Jul 2026
HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.
HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm
03:14pm, Sunday, 19'th Jul 2026
LOS ANGELES--(BUSINESS WIRE)---- $HCA--HCA Investors Have Opportunity to Join HCA Healthcare, Inc. Fraud Investigation with the Schall Law Firm.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
07:52pm, Thursday, 16'th Jul 2026
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to co
HCA Healthcare's Warning Prices In All The Bad News (Upgrade)
06:00am, Wednesday, 15'th Jul 2026
HCA Healthcare is upgraded to "Buy" after recent underperformance, with shares now reflecting payer mix and policy headwinds. HCA's Q2 results beat expectations due to a $400 million one-time Medicaid
HCA Healthcare Trims 2026 Profit Outlook, Stock Falls
09:41am, Tuesday, 14'th Jul 2026
HCA Healthcare Inc.'s (NYSE:HCA) stock is trading lower on Tuesday after cutting its fiscal 2026 earnings guidance from $29.10-$31.50 to $28.70-$30.50.
HCA Healthcare Stock Falls as Uninsured Patients and Declining Surgeries Dent Outlook
09:16am, Tuesday, 14'th Jul 2026
HCA Healthcare stock falls after the hospital chain operator lowers its full-year profit outlook as uninsured patients rise in the second quarter.
Sign In
Buy HCA